Better Coronavirus Stock: Johnson & Johnson vs. Novavax

Two very different drug companies recently joined the elite group of late-stage coronavirus vaccine companies. Johnson & Johnson (NYSE: JNJ) initiated a Phase 3 global clinical trial of JNJ-78436735 (also known as Ad26.COV2.S) on September 23. Novavax (NASDAQ: NVAX) started Phase 3 testing of its COVID-19 vaccine candidate in the UK the following day.

You should check here to buy the best price guaranteed products.

Last News

Fight Highlights: Martin "El Toro" Bravo vs. Andrew "The Beast" Whitney

Fight Highlights: Carlos "El Changuito" Calvo Calvo vs. Javier "Blair" Reyes

CG: ATL@SF - 9/17/21

France recalls envoys from U.S. and Australia

CG: OAK@LAA - 9/17/21

A’s vs. Angels Highlights